Financhill
Back

NovaBay Pharmaceuticals Stock Predictions

NovaBay Pharmaceuticals Stock Forecast

  • Is NovaBay Pharmaceuticals Stock Undervalued?
    The current NovaBay Pharmaceuticals [NBY] share price is $0.71. The Score for NBY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will NovaBay Pharmaceuticals Stock Go Up Next Year?

Data Unavailable

NovaBay Pharmaceuticals Stock Rating

Data Unavailable

NovaBay Pharmaceuticals Stock Price History

Is NBY stock going to rise?

  • The current trend is relatively stagnant and NBY is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NYAM
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
novabay.com

52-Week Data

52-Week High:
11.69
52-Week Low:
0.36

Prediction Charts

Market Cap:
3.46M
Price in USD:
0.71
Volume:
31.32K
Beta:
1.35

Technical Analysis

SMA50:
0.65
SMA100:
0.88
SMA200:
2.37
52-Wk Change:
-93.75%

Stock Predictions

  • Is NovaBay Pharmaceuticals stock public?
    Yes, NovaBay Pharmaceuticals is a publicly traded company.
  • What is the NovaBay Pharmaceuticals stock quote today?
    The NovaBay Pharmaceuticals stock price is 0.71 USD today.
  • How to buy NovaBay Pharmaceuticals stock online?
    You can buy NovaBay Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-1 0.75 0.75 0.75 0.68
Nov-4 0.73 0.76 0.79 0.70
Nov-5 0.76 0.76 0.77 0.74
Nov-6 0.74 0.72 0.76 0.70
Nov-7 0.73 0.70 0.74 0.67
Nov-8 0.72 0.69 0.72 0.64
Nov-11 0.69 0.71 0.74 0.66
Nov-12 0.72 0.78 0.82 0.70
Nov-13 0.76 0.71 0.81 0.71
Nov-14 0.75 0.73 0.75 0.70
Nov-15 0.71 0.71 0.74 0.69
Nov-18 0.71 0.70 0.72 0.69
Nov-19 0.72 0.70 0.72 0.69
Nov-20 0.70 0.71 0.73 0.68

NovaBay Pharmaceuticals Earnings

Data Unavailable

NovaBay Pharmaceuticals Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

* NovaBay Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.